Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection

  • Authors:
    • Susanna Alder
    • Claudia Perinetti
    • Miriam Mints
    • Karen Belkić
    • Karin Sundström
    • Sven Sandin
    • Elisabete Weiderpass
    • Sonia Andersson
  • View Affiliations

  • Published online on: July 19, 2013     https://doi.org/10.3892/ijo.2013.2023
  • Pages: 1310-1318
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical cancer is the second most common cancer among women in Argentina and the mortality has remained unchanged for the last 30 years. The 2011 national implementation of human papillomavirus (HPV) vaccination will be a key component of future cervical cancer prevention. Vaccination of young adult women is not included in the program, although these women could also benefit from the vaccine, especially in underserved areas with a high prevalence of HPV. However, research on acceptance of HPV vaccination within this group is scarce. The aim of this study was to investigate acceptance of HPV vaccination, the correlation between acceptance and cost, as well as other factors and perceptions of HPV vaccination among young adult women in Argentina. In total, 174 young women aged 18-30 years were included in this quantitative cross-sectional hospital-based study in a low resource area of the Mendoza Province, conducted through structured questionnaire-based interviews. Multinomial logistic regression models were used to investigate correlates of acceptance. Acceptance of HPV vaccination was high if it was free (95%) and even if it was not (75%). A significant positive association was found between acceptance and belief in vaccine safety (p=0.01) and between acceptance and not being a welfare recipient (p=0.00). Nearly half the participants incorrectly believed that they would be fully protected against cervical cancer after vaccination. Our findings suggest that acceptance of HPV vaccination is high among young women in a high-risk, relatively underserved area, even if vaccination is not free. Extensive misconceptions about the vaccine, however, highlight the need for further education about HPV vaccination.
View References

Related Articles

Journal Cover

October 2013
Volume 43 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Alder S, Perinetti C, Mints M, Belkić K, Sundström K, Sandin S, Weiderpass E and Andersson S: Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection. Int J Oncol 43: 1310-1318, 2013
APA
Alder, S., Perinetti, C., Mints, M., Belkić, K., Sundström, K., Sandin, S. ... Andersson, S. (2013). Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection. International Journal of Oncology, 43, 1310-1318. https://doi.org/10.3892/ijo.2013.2023
MLA
Alder, S., Perinetti, C., Mints, M., Belkić, K., Sundström, K., Sandin, S., Weiderpass, E., Andersson, S."Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection". International Journal of Oncology 43.4 (2013): 1310-1318.
Chicago
Alder, S., Perinetti, C., Mints, M., Belkić, K., Sundström, K., Sandin, S., Weiderpass, E., Andersson, S."Acceptance of human papillomavirus (HPV) vaccination among young women in a country with a high prevalence of HPV infection". International Journal of Oncology 43, no. 4 (2013): 1310-1318. https://doi.org/10.3892/ijo.2013.2023